Exact Mass: 344.1835
Exact Mass Matches: 344.1835
Found 500 metabolites which its exact mass value is equals to given mass value 344.1835,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Formoterol
Formoterol is a long-acting (12 hours) beta2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). Inhaled formoterol works like other beta2-agonists, causing bronchodilatation through relaxation of the smooth muscle in the airway so as to treat the exacerbation of asthma. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl)phenol
11-Dehydrocorticosterone
11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.) [HMDB] 11-Dehydrocorticosterone is a mineral corticosteroid. The conversion of inactive 11-ketoglucocorticoids such as 11-dehydrocorticosterone) into active 11b-hydroxyglucocorticoids (such as corticosterone) is catalyzed by 11beta-hydroxysteroid dehydrogenase (11b-HSD1, EC 1.1.1.146), which is expressed in many tissues and plays an important role in metabolically relevant tissues such as the liver, adipose tissue, skeletal muscles and possibly kidney. Chronically elevated local glucocorticoid action as a result of increased 11beta-HSD1 activity rather than elevated systemic glucocorticoid levels has been associated with metabolic syndrome, which is characterized by obesity, insulin resistance, type 2 diabetes and cardiovascular complications. Recent studies indicate that compounds inhibiting 11beta-HSD1 activity ameliorate the adverse effects of excessive glucocorticoid concentrations on metabolic processes, providing promising opportunities for the development of therapeutic interventions. 11-dehydrocorticosterone and corticosterone display antinatriuretic activity, although 11-dehydrocorticosterone is generally a more potent sodium retainer than corticosterone. (PMID: 17584152, Endocr Metab Immune Disord Drug Targets. 2007 Jun;7(2):125-40.).
alpha,alpha-Diethyl-4,4-bis(2-propynyloxy)stilbene
3-[(4aS,12aR)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl]phenol
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol, also known as delta(1)-Tetrahydrocannabinol-7-Oic acid or delta-9-11-Carboxytetrahydrocannabinol, is classified as a member of the 2,2-dimethyl-1-benzopyrans. 2,2-dimethyl-1-benzopyrans are organic compounds containing a 1-benzopyran moiety that carries two methyl groups at the 2-position. 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol is considered to be practically insoluble (in water) and acidic
(E,E)-Boviquinone 3
(E,E)-Boviquinone 3 is found in mushrooms. (E,E)-Boviquinone 3 is a pigment from Chroogomphus rutilus (pine spike cap Pigment from Chroogomphus rutilus (pine spike cap). (E,E)-Boviquinone 3 is found in mushrooms.
Neotussilagolactone
Neotussilagolactone is found in tea. Neotussilagolactone is a constituent of Tussilago farfara (coltsfoot) Constituent of Tussilago farfara (coltsfoot). Neotussilagolactone is found in tea.
Formebolone
Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003) [HMDB] Formebolone is a synthetic anabolic steroid. It is suspected of misuse in sports and therefore tested for in regular screening of athletes. The desire to artificially enhance physical performance in order to increase the chances to win in sports competition is supposedly as old as mankind itself. Already during the ancient Olympic Games, in approximately 200 B.C., athletes used concoctions of mushrooms and plant seeds, as well as special diets including bovine and canine testicles, as reported by Philostratos and Galen. The attempt to improve the power and strength of racing animals also has a long history, as it has been reported that the ancient Romans fed their horses so-called Hydromel, a mixture of honey and water, in order to increase endurance. The manipulation of the capacities of an athlete or animal has been referred to as doping since 1889, when this term, originating from a dialect spoken in the south-eastern region of Africa, was included in a British dictionary. With the athlete Linton, the first authentic doping-related death occurred in 1886 during a cycle race (Paris-Bordeaux), caused by an overdose of caffeine. (For a more complete review on doping see PMID: 15808003). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
19-Oxo-deoxycorticosterone
19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site. 19-hydroxydeoxycorticosterone (19,21-dihydroxy-4-pregnen-3,20-dione), 19-oxo-deoxycorticosterone (21-hydroxy-4-pregnen-3,19,20-trione), and 19-oic-deoxycorticosterone (19-oic-21-hydroxy-4-pregnen-3,20-dione)are formed from precursor deoxycorticosterone by adrenal glands obtained from intact rats and from rats undergoing adrenal regeneration.rat adrenals have the enzymes required to convert deoxycorticosterone to 19-hydroxydeoxycorticosterone, 19-oxo-deoxycorticosterone, and 19-oic-deoxycorticosterone; however, rat adrenals do not convert deoxycorticosterone or any of the oxygenated metabolites to 19-nor-deoxycorticosterone (21-hydroxy-19-nor-4-pregnen-3,20-dione). It is possible, however, that 19-nor-deoxycorticosterone is formed at peripheral sites from the oxygenated deoxycorticosterone precursors. 19-oxo-deoxycorticosterone (19-oxo-DOC) is a steroid recently isolated from the rat adrenal gland.19-Oxo-Deoxycorticosterone Binds to the Renal Mineralocorticoid Receptor and Produces Sodium Retention but Not Potassium Excretion.19-oxo-DOC both binds to type I renal mineralocor-ticoid receptors and produces the expected antinatriuretic effect of maximal doses of mineralocorticoids. This lack of a kaliuretic effect suggests that either 1) the kaliuretic effect of steroids such as aldosterone is mediated by a binding site other than the type I receptors, or 2) that potassium secretion mediated by aldoster-one-type I receptor interactions in discrete nephron target segments can be influenced by a steroid-sensitive potassium-recycling system in a more distal nephron site
Arformoterol
Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long acting beta agonists for the treatment of asthma. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(6Ar,10ar)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6h-benzo[c]chromene-9-carboxylic acid
7-Oxodehydroepiandrosterone 3-acetate
21-Deoxycortisone
4-Acetoxy-4-androstene-3,17-dione
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
15,16-Epoxy-20-oxo-8(17),13(16),14-labdatrien-19-oic acid methyl ester
[4S-[4alpha(E),4aalpha,5alpha,8abeta]]-4,4a,5,6,7,8,8a,9-Octahydro-3,4a,5-trimethyl-9-oxonaphtho[2,3-b]furan-4-yl ester 3-methyl-2-pentenoic acid
12-Methyl-5-dehydrohorminone
An abietane diterpenoid that is 5-dehydrohorminone in which the hydroxy group at position 12 is replaced by a methoxy group. Isolated from the roots of Salvia multicaulis, it exhibits antitubercular activity.
6,12-dihydroxy-11-methoxyabieta-5,8,11,13-tetraen-7-one
3beta-acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methyl-podocarpane-8,11,13-trien-7-one|3beta-acetoxy-12-methoxy-13-methylpodocarpa-8,11,13-trien-7-one|3??-Acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one.
(4R,9R)-10-hydroxy-13-methoxy-9-methyl-15-oxo-20-norkaur-16-en-18-oic acid gamma-lactone
2,11beta-Dimethoxy-3-hydoxo-D-homoestra-1,3,5(10)trien-17a-on
(2E)-1,4-diacetoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene
6beta-hydroxy-3beta-<4-methylsenecioyloxy>-euryopsin
Methyl 15,16-epoxy-12-oxo-8(17),13(16),14-ent-labdatrien-19-oate
15-desmethoxy-16-oxo-15,16H-seco-nidoresedic acid methyl ester|15-desmethoxy-16-oxo-15,16H-strictic acid methyl ester|methyl ester of 16-oxo-15,16H-strictic acid
5alpha-Hydroxyconyscabrasaeure-methylester|methyl 5alpha-hydroxyconyscabroate
4beta-hydroxy-5beta,6beta-epoxypregn-2-ene-1,20-dione
(6aR,8R,9aR)-8-methoxy-6a-methyl-8-pentyl-3-((E)-prop-1-enyl)-6a,8,9,9atetrahydro-6H-furo[2,3-h]-isochromen-6-one|monapurone C
12-methylcoleon U|6,11-dihydro-12-methoxy-5,8,11,13-abietatetraen-7-one
Acetamide, N,N-[[(2S,5S)-3,6-dioxo-2,5-piperazinediyl]di-3,1-propanediyl]bis[N-hydroxy-
16-methoxy-6-oxo-7,11,13-labdatrien-16,15-olide|spicatanol methyl ether
5alpha-hydroxy-1,2-dehydro-5,10-dihydroprintzianic acid methyl ester|5alpha-Hydroxy-1,2-dehydro-5,10-dihydroprintziasaeure-methylester
4a.alpha.,4b.beta.-Gibbane-1.alpha.,10.beta.-dicarboxylic acid, 4a-(hydroxymethyl)-1-methyl-8-methylene-, 1,4a-lactone, methyl ester
8beta-hydroxy-14(17)-ene-18alpha-methoxycarbonyl-18-norvouacapene|mimosol A
15-oxo-14,16H-seco-nidoresedic acid methyl ester|15-oxo-14,16H-strictic acid methyl ester
3,5,5-trimethyl-4-(2-beta-D-glucopyranosyloxy)ethyl-cyclohexa-2-en-1-one
methyl 14beta-hydroxy-12-oxo-3,4-secopimara-7,9(11),13,15,19(4)-tetraen-3-oate|trigonoheterene
7beta-methoxy-8,11,13-triene-18,6alpha-abietanolide|liquidambolide A
15beta,17alpha-dihydroxypregna-4,6-diene-3,20-dione
4-O-[6,7-dihydro-5,6E-dehydro-7(9)-dehydrogeranyl]-sinapyl alcohol
4-O-geranyl-sinapyl aldehyde|4-O-geranylsinapyl aldehyde|geranyloxy sinapyl aldehyde|Nelumal A
5-methoxy-11.14-dioxo-abiata-8,12,15-triene|bractealine
13-dehydroxysarcoglaucol-16-one|2,5,6,9,10,13,14,16-octahydro-4,12,15-trimethyl-16-oxocyclotetradeca[b]furan-8-carboxylic acid methyl ester
Triptonoditerpenic acid
(E,E)-1,11-bis(furan-3-yl)-4,8-dimethylundeca-7,10-diene-4,6-diol|Untenospongin A
formoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Rhodotorulic acid
A member of the class of 2,5-diketopiperazines obtained by cyclodimerisation of N(5)-acetyl-N(5)-hydroxy-L-ornithine. Rhodotorulic acid is a member of the class of 2,5-diketopiperazines obtained by cyclodimerisation of N(5)-acetyl-N(5)-hydroxy-L-ornithine. It has a role as a siderophore and a fungal metabolite. It is a member of 2,5-diketopiperazines, a hydroxamic acid and a L-ornithine derivative. Rhodotorulic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=18928-00-2 (retrieved 2024-12-11) (CAS RN: 18928-00-2). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Ala Ala Pro Ser
Ala Ala Ser Pro
Ala Gly Pro Thr
Ala Gly Thr Pro
Ala Pro Ala Ser
Ala Pro Gly Thr
Ala Pro Ser Ala
Ala Pro Thr Gly
Ala Ser Ala Pro
Ala Ser Pro Ala
Ala Thr Gly Pro
Ala Thr Pro Gly
Gly Ala Pro Thr
Gly Ala Thr Pro
Gly Pro Ala Thr
Gly Pro Thr Ala
Gly Thr Ala Pro
Gly Thr Pro Ala
Pro Ala Ala Ser
Pro Ala Gly Thr
Pro Ala Ser Ala
Pro Ala Thr Gly
Pro Gly Ala Thr
Pro Gly Thr Ala
Pro Ser Ala Ala
Pro Thr Ala Gly
Pro Thr Gly Ala
Ser Ala Ala Pro
Ser Ala Pro Ala
Ser Pro Ala Ala
Thr Ala Gly Pro
Thr Ala Pro Gly
Thr Gly Ala Pro
Thr Gly Pro Ala
Thr Pro Ala Gly
Thr Pro Gly Ala
4-[4-(3,4-Dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
11-DEHYDROCORTICOSTERONE
An 11-oxo steroid that is corticosterone in which the hydroxy substituent at the 11beta position has been oxidised to give the corresponding ketone. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Arformoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(E,E)-Boviquinone 3
Neotussilagolactone
Formebolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
ST 21:4;O4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
benoxinate hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
1-BOC-3-(4-TRIFLUOROMETHYL-PHENYLAMINO)-PIPERIDINE
1-BOC-3-(3-TRIFLUOROMETHYL-PHENYLAMINO)-PIPERIDINE
[1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-(1-piperidinyl)-1H-indo l-2-yl]boronic acid
4-[1-hydroxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]benzene-1,2-diol
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
1-BOC-3-([(2-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
1-BOC-3-([(3-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
1-BOC-3-([(4-TRIFLUOROMETHYL-PHENYL)-AMINO]-METHYL)-PYRROLIDINE
tert-butyl 4-[4-(trifluoromethyl)anilino]piperidine-1-carboxylate
tolamolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
1-{2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL}-2-METHYL-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID
tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine-1-carboxylate
2-methyl-4-[(2-propoxybenzoyl)amino]-5-propylpyrazole-3-carboxamide
1H-PYRIDO[3,4-B]INDOLE-1-ACETIC ACID, 2-[(1,1-DIMETHYLETHOXY)CARBONYL]-2,3,4,9-TETRAHYDRO-, METHYL ESTER
(S)-1,4-Di-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate
(R)-1,4-di-Boc-piperazine-2-carboxylic acid Methyl ester
tert-butyl 3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
Sodium 2-[methyl(1-oxododecyl)amino]ethanesulphonate
1,4-DI-TERT-BUTYL 2-METHYL PIPERAZINE-1,2,4-TRICARBOXYLATE
Anecortave
S - Sensory organs > S01 - Ophthalmologicals > S01L - Ocular vascular disorder agents > S01LA - Antineovascularisation agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Mivavotinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S,S)-Formoterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents COVID info from clinicaltrials, clinicaltrial Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Triptobenzene H
An abietane diterpenoid with formula C21H28O4, originally isolated from Tripterygium wilfordii.
4-Amino-3-butoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
(S)-codamine(1+)
An ammonium ion derivative resulting from the protonation of the amino group of (S)-codamine. The major species at pH 7.3.
L-Lys-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH
(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoic acid
[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] propanoate
4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
N-cyclohexyl-1-hydroxy-5-nitro-4-spiro[benzimidazole-2,1-cyclohexane]imine
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine
1-[1-(4-Butan-2-ylphenyl)ethyl]-3-[(4-fluorophenyl)methyl]thiourea
1-[(4-Fluorophenyl)methyl]-3-[1-(4-propan-2-ylphenyl)propyl]thiourea
7-Hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium
19-Oxo-deoxycorticosterone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Laudanine(1+)
An organic cation that is the conjugate acid of laudanine, obtained by protonation of the tertiary amino group.
1-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-3-thiophen-2-ylurea
[2-(3,4-Dimethylphenyl)-4-quinolinyl]-(1-piperidinyl)methanone
1-(tert-butyl)-4-[({[(4-methoxyanilino)carbonyl]oxy}imino)methyl]-3,5-dimethyl-1H-pyrazole
(6aR)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c][1]benzopyran-9-carboxylic acid
2-Hydroxy-5-[1-hydroxy-2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzamide
6-De(cyclopropylamino)-6-(3-cyclopropyl-3-fluoroazetidin-1-yl)abacavir
6-De(cyclopropylamino)-6-(3-isopropoxyazetidin-1-yl)abacavir
2,3-Dihydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
4-Ethoxycarbonyl-6-ethyl-5-methyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)
4-Ethoxycarbonyl-6-ethyl-5-methyl-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-cis-6,6A-trans)
3-[(4Ar,12aS)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl]phenol
(R)-tetrahydropapaverine(1+)
An organic cation that is the conjugate acid of (R)-tetrahydropapaverine, obtained by protonation of the secondary amino group; major species at pH 7.3.
11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol
A phytocannabinoid that is Delta(9)-tetrahydrocannabinol in which the C-11 methyl has been fully oxidised to a carboxy group. Further enzymatic oxidation product of 11-hydroxy-Delta(9)-tetrahydrocannabinol.
21-deoxycortisone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(-)-(8R,8S)-3,3,4-trimethoxy-4-hydroxylignan
A lignan that is 2,3-dimethylbutane substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a 3,4-dimethoxyphenyl group at position 4. It has been isolated from the bark of Machilus robusta.
(S)-tembetarine
A tembetarine obtained by methylation of the tertiary amino function of (R)-reticuline.
1-{7,8,11-trihydroxy-9a,11a-dimethyl-3h,3ah,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone
methyl (4ar,5s,6r,8as)-8a-formyl-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
methyl (4r,4ar,6as,7r,11as,11bs)-11b-formyl-4,7-dimethyl-1h,2h,3h,4ah,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-4-carboxylate
methyl (9r,10e,16z)-9-(acetyloxy)octadeca-10,16-dien-12,14-diynoate
(2e,4e)-n-{3-[(4e)-5-hydroxy-4-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-3-oxo-2h-pyrrol-2-yl]propyl}hexa-2,4-dienimidic acid
methyl (1r,4as,5r,8as)-5-[2-(furan-3-yl)-2-oxoethyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
(4as,10as)-5-hydroxy-7-isopropyl-8-methoxy-1,4a-dimethyl-4,9,10,10a-tetrahydro-3h-phenanthrene-2-carboxylic acid
2-(3,7-dimethylocta-2,6-dien-1-yl)-3,5-dihydroxy-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione
(1r,8r,9s,10s)-3,4,8-trihydroxy-5-isopropyl-11,11-dimethyltetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5-trien-15-one
1-(dec-9-en-1-yl)-2-hydroxybutane-1,2,4-tricarboxylic acid
3-[3-hydroxy-6-isopropyl-2-(methoxycarbonyl)-3-(methoxymethyl)cyclohexyl]-2-(hydroxymethyl)prop-2-enoic acid
methyl 6,7-dimethyl-10-methylidene-6-[2-(2-oxo-5h-furan-3-yl)ethyl]cyclodeca-1,3-diene-1-carboxylate
methyl 10,15-dimethyl-3,6-dioxapentacyclo[9.7.1.0¹,¹⁴.0⁴,¹⁹.0⁵,⁹]nonadeca-5(9),7-diene-15-carboxylate
11-hydroxy-3-methyl-6-(6-methyl-5-oxohept-6-en-2-yl)-2-oxatricyclo[7.4.0.0³,⁷]trideca-1(9),5-dien-10-one
(1s,3r,7s,8s,8ar)-3,7-dimethyl-8-{2-[(2r)-6-oxo-2,3-dihydropyran-2-yl]ethyl}-1,2,3,7,8,8a-hexahydronaphthalen-1-yl acetate
(1s,2s,5s,6r,9r,11r,12s,13r)-6,11-dihydroxy-6,13-dimethyl-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one
4-[(2s,3s)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
(2e,6r)-6-[(3r,7s,11r)-11-hydroxy-3-methyl-10-oxo-2-oxatricyclo[7.4.0.0³,⁷]trideca-1(9),5-dien-6-yl]-2-methylhept-2-enal
(2e,4e)-n-(3-{4-[(2e,4e)-hexa-2,4-dienoyl]-5-hydroxy-3-oxo-1,2-dihydropyrrol-2-yl}propyl)hexa-2,4-dienimidic acid
(6ar,8s,9ar)-8-methoxy-6a-methyl-8-pentyl-3-[(1e)-prop-1-en-1-yl]-9h,9ah-furo[2,3-h]isochromen-6-one
(1s,2s,5s,9r,11r,12s,13r)-6,11-dihydroxy-6,13-dimethyl-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one
methyl (4r,4ar,6as,7r,11as,11br)-4-formyl-7,11b-dimethyl-1h,2h,3h,4ah,5h,6h,6ah,7h,11h,11ah-phenanthro[3,2-b]furan-4-carboxylate
5-{6,7-dihydroxy-5-methyl-4-oxo-3,11-dioxabicyclo[6.2.1]undecan-2-yl}pentyl acetate
11-amino-3,4-dimethoxy-13-methyl-9-oxa-13-azapentacyclo[9.4.2.1⁸,¹².0¹,¹².0²,⁷]octadeca-2,4,6-trien-10-one
4-[2-(2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)ethenyl]-5-methoxy-5h-furan-2-one
methyl (1s,4as,5s,8ar)-4a-formyl-5-[2-(furan-3-yl)ethyl]-1-methyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate
methyl 8a-formyl-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
methyl (3as,15as)-6,14-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,12h,13h,15ah-cyclotetradeca[b]furan-10-carboxylate
(2e)-3-(4-{[(2e,5e)-3,7-dimethylocta-2,5,7-trien-1-yl]oxy}-3,5-dimethoxyphenyl)prop-2-en-1-ol
4-(3,7-dimethylocta-2,6-dien-1-yl)-3,5-dihydroxy-6-(3-methylbut-2-en-1-yl)cyclohexa-3,5-diene-1,2-dione
4-[(2r,3s)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol
6,7-dihydroxy-2,4b-dimethyl-2-(2-methylfuran-3-yl)-4,4a,5,6,7,8,10,10a-octahydro-3h-phenanthren-1-one
(6s,6ar,10as)-5-hydroxy-4-isopropyl-7,7,10a-trimethyl-2h,6h,6ah,8h,9h,10h-fluoreno[3,4-d][1,3]dioxole-6-carbaldehyde
(4br,8ar)-1-hydroxy-8a-methoxy-4b,8,8-trimethyl-2-(prop-1-en-2-yl)-6,7,9,10-tetrahydro-5h-phenanthrene-3,4-dione
methyl 3-[2-(furan-3-yl)ethyl]-6a-hydroxy-3,4-dimethyl-2ah,2bh,4h,5h,6h,7h-cyclobuta[a]indene-7a-carboxylate
1-(1,2-dihydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,8h,9h,9bh,10h-cyclopenta[a]phenanthrene-7,11-dione
methyl 11-methyl-6-methylidene-12-oxo-13-oxapentacyclo[9.3.3.1⁵,⁸.0¹,¹⁰.0²,⁸]octadecane-9-carboxylate
3β-acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one.
{"Ingredient_id": "HBIN008130","Ingredient_name": "3\u03b2-acetoxy-12-methoxy-13-methyl-podocarpa-8,11,13-trien-7-one.","Alias": "NA","Ingredient_formula": "C21H28O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "254","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adonilide
{"Ingredient_id": "HBIN014729","Ingredient_name": "adonilide","Alias": "NA","Ingredient_formula": "C21H28O4","Ingredient_Smile": "CC12CCC(CC1=CCC3C2CCC45C36CCC4C(O6)(OC5=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "644","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agastanol
{"Ingredient_id": "HBIN014828","Ingredient_name": "agastanol","Alias": "NA","Ingredient_formula": "C21H28O4","Ingredient_Smile": "NA","Ingredient_weight": "344.44","OB_score": "NA","CAS_id": "160896-57-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7116","PubChem_id": "NA","DrugBank_id": "NA"}
anhydrohirundigenin
{"Ingredient_id": "HBIN016161","Ingredient_name": "anhydrohirundigenin","Alias": "NA","Ingredient_formula": "C21H28O4","Ingredient_Smile": "CC12CCC(CC1=CCC3=C4C5(CCC23)COC6(C5C(O4)CO6)C)O","Ingredient_weight": "344.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1271","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102060418","DrugBank_id": "NA"}
